Concise review: The epigenetic contribution to stem cell ageing: Can we rejuvenate our older cells?

Stem Cells

Volumn 32, Issue 9, 2014, Pages 2291-2298

  Armstrong, Lyle ^a   Al Aama, Jumana ^b   Stojkovic, Miodrag ^c   Lako, Majlinda ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^c University of Kragujevac Medical Faculty   (Serbia)

Author keywords

Ageing; DNA damage; Epigenetics; Mitochondria; Stem cells

Indexed keywords

AGING; CELL AGING; CELL DAMAGE; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; DNA DAMAGE; DNA METHYLATION; EPIGENETICS; GENOMIC INSTABILITY; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; MACROMOLECULE; MESENCHYMAL STEM CELL; MICROENVIRONMENT; MITOCHONDRION; PHENOTYPE; REJUVENATION; REVIEW; STEM CELL; TISSUE REPAIR; TISSUE SPECIFICITY; ANIMAL; CYTOLOGY; GENETIC EPIGENESIS; GENETICS; HUMAN; PHYSIOLOGY;

ANIMALS; CELL AGING; EPIGENESIS, GENETIC; HUMANS; STEM CELLS;

EID: 84906227983     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1720     Document Type: Review

References (93)

1. Raveh-Amit H, Berzsenyi S, Vas V, et al. Tissue resident stem cells: Till death do us part. Biogerontology 2013; 14: 573-590.
2. Carlson ME, Conboy IM,. Loss of stem cell regenerative capacity within aged niches. Aging Cell 2007; 6: 371-382.
3. Sager R,. Senescence as a mode of tumor suppression. Environ Health Perspect 1991; 93: 59-62.
4. Weinstein BS, Ciszek D,. The reserve-capacity hypothesis: Evolutionary origins and modern implications of the trade-off between tumor-suppression and tissue-repair. Exp Gerontol 2002; 37: 615-627.
5. Pearson BJ, Sánchez Alvarado A,. Regeneration, stem cells, and the evolution of tumor suppression. Cold Spring Harb Symp Quant Biol 2008; 73: 565-572.
6. Nižetic̈ D, Groet J,. Tumorigenesis in Down's syndrome: Big lessons from a small chromosome. Nat Rev Cancer 2012; 12: 721-732.
7. Garinis GA, van der Horst GT, Vijg J, et al. DNA damage and ageing: New-age ideas for an age-old problem. Nat Cell Biol 2008; 10: 1241-1247.
8. Lombard DB, Chua KF, Mostoslavsky R, et al. DNA repair, genome stability, and aging. Cell 2005; 120: 497-512.
9. Vijg J,. Impact of genome instability on transcription regulation of aging and senescence. Mech Ageing Dev 2004; 125: 747-753.
10. Campisi J,. Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors. Cell 2005; 120: 513-522.
11. Saretzki G, Von Zglinicki T,. Replicative aging, telomeres, and oxidative stress. Ann N Y Acad Sci 2002; 959: 24-29.
12. von Zglinicki T, Petrie J, Kirkwood TB,. Telomere-driven replicative senescence is a stress response. Nat Biotechnol 2003; 21: 229-230.
13. Bohr VA,. Rising from the RecQ-age: The role of human RecQ helicases in genome maintenance. Trends Biochem Sci 2008; 33: 609-620.
14. Gray MD, Shen JC, Kamath-Loeb AS, et al. The Werner syndrome protein is a DNA helicase. Nat Genet 1997; 17: 100-103.
15. De Sandre-Giovannoli A, Bernard R, Cau P, et al. Lamin a truncation in Hutchinson-Gilford progeria. Science 2003; 300: 2055.
16. Vilchez D, Simic MS, Dillin A,. Proteostasis and aging of stem cells. Trends Cell Biol 2014; 24: 161-170.
17. Arslan MA, Csermely P, Soti C,. Protein homeostasis and molecular chaperones in aging. Biogerontology 2006; 7: 383-389.
18. Porta EA,. Pigments in aging: An overview. Ann N Y Acad Sci 2002; 959: 57-65.
19. Jung T, Bader N, Grune T,. Lipofuscin: Formation, distribution, and metabolic consequences. Ann N Y Acad Sci 2007; 1119: 97-111.
20. Chambers SM, Shaw CA, Gatza C, et al. Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol 2007; 5: e201.
21. Warren LA, Rossi DJ,. Stem cells and aging in the hematopoietic system. Mech Ageing Dev 2009; 130: 46-53.
22. Sinclair DA, Oberdoerffer P,. The ageing epigenome: Damaged beyond repair? Ageing Res Rev 2009; 8: 189-198.
23. Di Bernardo G, Cipollaro M, Galderisi U,. Chromatin modification and senescence. Curr Pharm Des 2012; 18: 1686-1693.
24. Maegawa S, Hinkal G, Kim HS, et al. Widespread and tissue specific age-related DNA methylation changes in mice. Genome Res 2010; 20: 332-340.
25. Hannum G, Guinney J, Zhao L, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell 2013; 49: 359-367.
26. Horvath S,. DNA methylation age of human tissues and cell types. Genome Biol 2013; 14: R115.
27. Jenuwein T, Allis CD,. Translating the histone code. Science 2001; 293: 1074-1080.
28. Strahl BD, Allis CD,. The language of covalent histone modifications. Nature 2000; 403: 41-45.
29. Dimauro T, David G., Chromatin modifications: The driving force of senescence and aging? Aging (Albany NY) 2009; 1: 182-190.
30. Shin DM, Kucia M, Ratajczak MZ,. Nuclear and chromatin reorganization during cell senescence and aging-A mini-review. Gerontology 2011; 57: 76-84.
31. Rhie BH, Song YH, Ryu HY, et al. Cellular aging is associated with increased ubiquitylation of histone H2B in yeast telomeric heterochromatin. Biochem Biophys Res Commun 2013; 439: 570-575.
32. Liu L, Cheung TH, Charville GW, et al. Chromatin modifications as determinants of muscle stem cell quiescence and chronological aging. Cell Rep 2013; 4: 189-204.
33. Sarraf SA, Stancheva I,. Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly. Mol Cell 2004; 15: 595-605.
34. Davey CS, Pennings S, Reilly C, et al. A determining influence for CpG dinucleotides on nucleosome positioning in vitro. Nucleic Acids Res 2004; 32: 4322-4331.
35. Fuks F,. DNA methylation and histone modifications: Teaming up to silence genes. Curr Opin Genet Dev 2005; 15: 490-495.
36. Harman D,. The aging process. Proc Natl Acad Sci USA 1981; 78: 7124-7128.
37. Harman D,. The free radical theory of aging. Antioxid Redox Signal 2003; 5: 557-561.
38. Croteau DL, Bohr VA,. Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem 1997; 272: 25409-25412.
39. Khrapko K, Vijg J,. Mitochondrial DNA mutations and aging: Devils in the details? Trends Genet 2009; 25: 91-98.
40. Greaves LC, Barron MJ, Plusa S, et al. Defects in multiple complexes of the respiratory chain are present in ageing human colonic crypts. Exp Gerontol 2010; 45: 573-579.
41. Pang WW, Price EA, Sahoo D, et al. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci USA 2011; 108: 20012-20017.
42. Kuranda K, Vargaftig J, de la Rochere P, et al. Age-related changes in human hematopoietic stem/progenitor cells. Aging Cell 2011; 10: 542-546.
43. Muller-Sieburg C, Sieburg HB,. Stem cell aging: Survival of the laziest? Cell Cycle 2008; 7: 3798-3804.
44. Dykstra B, Olthof S, Schreuder J, et al. Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells. J Exp Med 2011; 208: 2691-2703.
45. Beerman I, Bhattacharya D, Zandi S, et al. Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc Natl Acad Sci USA 2010; 107: 5465-5470.
46. Solbach U, Keilhauer C, Knabben H, et al. Imaging of retinal autofluorescence in patients with age-related macular degeneration. Retina 1997; 17: 385-389.
47. Fuchs R, Schraml E, Leitinger G, et al. α1-Adrenergic drugs modulate differentiation and cell death of human erythroleukemia cells through non adrenergic mechanism. Exp Cell Res 2011; 317: 2239-2251.
48. Yahata T, Takanashi T, Muguruma Y, et al. Accumulation of oxidative DNA damage restricts the self-renewal capacity of human hematopoietic stem cells. Blood 2011; 118: 2941-2950.
49. Shin MG, Kajigaya S, McCoy JP Jr, et al. Marked mitochondrial DNA sequence heterogeneity in single CD34+ cell clones from normal adult bone marrow. Blood 2004; 103: 553-561.
50. Yao YG, Kajigaya S, Feng X, et al. Accumulation of mtDNA variations in human single CD34+ cells from maternally related individuals: Effects of aging and family genetic background. Stem Cell Res 2013; 10: 361-370.
51. Norddahl GL, Pronk CJ, Wahlestedt M, et al. Accumulating mitochondrial DNA mutations drive premature hematopoietic aging phenotypes distinct from physiological stem cell aging. Cell Stem Cell 2011; 8: 499-510.
52. Florian MC, Geiger H,. Concise review: Polarity in stem cells, disease, and aging. Stem Cells 2010; 8: 1623-1629.
53. Florian MC, Dörr K, Niebel A, et al. Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation. Cell Stem Cell 2012; 10: 520-530.
54. Rios RM, Bornens M,. The Golgi apparatus at the cell centre. Curr Opin Cell Biol 2003; 15: 60-66.
55. Krummel MF, Macara I,. Maintenance and modulation of T cell polarity. Nat Immunol 2006; 7: 1143-1149.
56. Geiger H, Koehler A, Gunzer M,. Stem cells, aging, niche, adhesion and Cdc42: A model for changes in cell-cell interactions and hematopoietic stem cell aging. Cell Cycle 2007; 6: 884-887.
57. Xing Z, Ryan MA, Daria D, et al. Increased hematopoietic stem cell mobilization in aged mice. Blood 2006; 108: 2190-2197.
58. Wang L, Yang L, Debidda M, et al. Cdc42 GTPase-activating protein deficiency promotes genomic instability and premature aging-like phenotypes. Proc Natl Acad Sci USA 2007; 104: 1248-1253.
59. Apostolou E, Hochedlinger K,. Chromatin dynamics during cellular reprogramming. Nature 2013; 502: 462-471.
60. Wahlestedt M, Norddahl GL, Sten G, et al. An epigenetic component of hematopoietic stem cell aging amenable to reprogramming into a young state. Blood 2013; 121: 4257-4264.
61. Chamberlain G, Fox J, Ashton B, et al. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007; 25: 2739-2749.
62. Nöth U, Rackwitz L, Steinert AF, et al. Cell delivery therapeutics for musculoskeletal regeneration. Adv Drug Deliv Rev 2010; 62: 765-783.
63. Chen Y, Shao JZ, Xiang LX, et al. Mesenchymal stem cells: A promising candidate in regenerative medicine. Int J Biochem Cell Biol 2008; 40: 815-820.
64. Wu XB, Tao R,. Hepatocyte differentiation of mesenchymal stem cells. Hepatobiliary Pancreat Dis Int 2012; 11: 360-371.
65. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
66. Lepperdinger G,. Inflammation and mesenchymal stem cell aging. Curr Opin Immunol 2011; 23: 518-524.
67. Chen JH, Yip CY, Sone ED, et al. Identification and characterization of aortic valve mesenchymal progenitor cells with robust osteogenic calcification potential. Am J Pathol 2009; 174: 1109-1119.
68. Choumerianou DM, Martimianaki G, Stiakaki E, et al. Comparative study of stemness characteristics of mesenchymal cells from bone marrow of children and adults. Cytotherapy 2010; 12: 881-887.
69. Wagner W, Bork S, Horn P, et al. Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS One 2009; 4: e5846.
70. Laschober GT, Brunauer R, Jamnig A, et al. Age-specific changes of mesenchymal stem cells are paralleled by upregulation of CD106 expression as a response to an inflammatory environment. Rejuvenat Res 2011; 14: 119-131.
71. Zhang J, Lian Q, Zhu G, et al. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 2011; 8: 31-45.
72. Csoka AB, English SB, Simkevich CP, et al. Genome-scale expression profiling of Hutchinson-Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis. Aging Cell 2004; 3: 235-243.
73. Scaffidi P, Misteli T,. Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat Cell Biol 2008; 10: 452-459.
74. Cao K, Blair CD, Faddah DA, et al. Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal human fibroblasts. J Clin Invest 2011; 121: 2833-2844.
75. Miller JD, Ganat YM, Kishinevsky S, et al. Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell 2013; 13: 691-705.
76. Alves H, Munoz-Najar U, De Wit J, et al. A link between the accumulation of DNA damage and loss of multi-potency of human mesenchymal stromal cells. J Cell Mol Med 2010; 14: 2729-2738.
77. Altanerova V, Horvathova E, Matuskova M, et al. Genotoxic damage of human adipose-tissue derived mesenchymal stem cells triggers their terminal differentiation. Neoplasma 2009; 56: 542-547.
78. Galderisi U, Helmbold H, Squillaro T, et al. In vitro senescence of rat mesenchymal stem cells is accompanied by downregulation of stemness-related and DNA damage repair genes. Stem Cells Dev 2009; 18: 1033-1042.
79. Bork S, Pfister S, Witt H, et al. DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 2010; 9: 54-63.
80. Saini A, Mastana S, Myers F, et al. 'From death, lead me to immortality'-Mantra of ageing skeletal muscle. Curr Genomics 2013; 14: 256-267.
81. Zammit PS, Partridge TA, Yablonka-Reuveni Z,. The skeletal muscle satellite cell: The stem cell that came in from the cold. J Histochem Cytochem 2006; 54: 1177-1191.
82. Sharples AP, Al-Shanti N, Lewis MP, et al. Reduction of myoblast differentiation following multiple population doublings in mouse C2 C12 cells: A model to investigate ageing? J Cell Biochem 2011; 112: 3773-3785.
83. Conboy IM, Rando TA,. Aging, stem cells and tissue regeneration: Lessons from muscle. Cell Cycle 2005; 4: 407-410.
84. Brack AS, Conboy MJ, Roy S, et al. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 2007; 317: 807-810.
85. Cousin W, Ho ML, Desai R, et al. Regenerative capacity of old muscle stem cells declines without significant accumulation of DNA damage. PLoS One 2013; 8: e63528.
86. Rodier F, Coppé JP, Patil CK, et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 2009; 11: 973-979.
87. Tchkonia T, Zhu Y, van Deursen J, et al. Cellular senescence and the senescent secretory phenotype: Therapeutic opportunities. J Clin Invest 2013; 123: 966-972.
88. Baker DJ, Wijshake T, Tchkonia T, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011; 479: 232-236.
89. Kuhn HG, Dickinson-Anson H, Gage FH,. Neurogenesis in the dentate gyrus of the adult rat: Age-related decrease of neuronal progenitor proliferation. J Neurosci 1996; 16: 2027-2033.
90. Maslov AY, Barone TA, Plunkett RJ, et al. Neural stem cell detection, characterization, and age-related changes in the subventricular zone of mice. J Neurosci 2004; 24: 1726-1733.
91. Molofsky AV, Slutsky SG, Joseph NM, et al. Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 2006; 443: 448-452.
92. Villeda SA, Luo J, Mosher KI, et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 2011; 477: 90-94.
93. Seib DR, Corsini NS, Ellwanger K, et al. Loss of Dickkopf-1 restores neurogenesis in old age and counteracts cognitive decline. Cell Stem Cell 2013; 12: 204-214.